SEARCH

SEARCH BY CITATION

References

  • Abraham J., Jang S., Godbout J. P., Chen J., Kelley K. W., Dantzer R. and Johnson R. W. (2006) Aging sensitizes mice to behavioral deficits induced by central HIV-1 gp120. Neurobiol. Aging 29, 614621.
  • Akira S., Isshiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y., Nakajima T., Hirano T. and Kishimoto T. (1990) A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9, 18971906.
  • Alberini C. M., Ghirardi M., Metz R. and Kandel E. R. (1994) C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia. Cell 76, 10991114.
  • Albertini J. J., Sujka S. K., Helal M. A., Seigne J. D. and Lockhart J. L. (1998) Adenocarcinoma in a continent colonic urinary reservoir. Urology 51, 499500.
  • Borjabad A., Brooks A. I. and Volsky D. J. (2009) Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders. J. Neuroimmune Pharmacol. 5, 4462.
  • Brambilla R., Bracchi-Ricard V., Hu W. H., Frydel B., Bramwell A., Karmally S., Green E. J. and Bethea J. R. (2005) Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 202, 145156.
  • Brambilla R., Persaud T. and Hu X. et al. (2009) Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J. Immunol. 182, 26282640.
  • Bugno M., Witek B., Bereta J., Bereta M., Edwards D. R. and Kordula T. (1999) Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines. FEBS Lett. 448, 914.
  • Cardinaux J. R., Allaman I. and Magistretti P. J. (2000) Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes. Glia 29, 9197.
  • Chaillan F. A., Rivera S., Marchetti E., Jourquin J., Werb Z., Soloway P. D., Khrestchatisky M. and Roman F. S. (2006) Involvement of tissue inhibition of metalloproteinases-1 in learning and memory in mice. Behav. Brain Res. 173, 191198.
  • Chen C., Chai H. and Wang X. et al. (2008) Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells. Blood 112, 32053216.
  • Clark I. M., Rowan A. D., Edwards D. R., Bech-Hansen T., Mann D. A., Bahr M. J. and Cawston T. E. (1997) Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1. Biochem. J. 324(Pt 2), 611617.
  • Cortes-Canteli M., Wagner M., Ansorge W. and Perez-Castillo A. (2004) Microarray analysis supports a role for ccaat/enhancer-binding protein-beta in brain injury. J. Biol. Chem. 279, 1440914417.
  • Crocker S., Whitmire J., Frausto R., Chertboonmuang P., Soloway P., Whitton J. and Campbell I. (2006) Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice. Am. J. Pathol. 169, 21042116.
  • Dean G. and Clark I. M. (1999) Transcriptional regulation of the human tissue inhibitor of metalloproteinases-1: mapping transcriptional control in intron-1. Ann. NY Acad. Sci. 878, 510511.
  • Dean G., Young D. A., Edwards D. R. and Clark I. M. (2000) The human tissue inhibitor of metalloproteinases (TIMP)-1 gene contains repressive elements within the promoter and intron 1. J. Biol. Chem. 275, 3266432671.
  • Dhar A., Gardner J., Borgmann K., Wu L. and Ghorpade A. (2006) Novel role of TGF-beta in differential astrocyte-TIMP-1 regulation: implications for HIV-1-dementia and neuroinflammation. J. Neurosci. Res. 83, 12711280.
  • Ejarque-Ortiz A., Medina M. G., Tusell J. M., Perez-Gonzalez A. P., Serratosa J. and Saura J. (2007) Upregulation of CCAAT/enhancer binding protein beta in activated astrocytes and microglia. Glia 55, 178188.
  • Fassina G., Ferrari N., Brigati C., Benelli R., Santi L., Noonan D. M. and Albini A. (2000) Tissue inhibitors of metalloproteases: regulation and biological activities. Clin. Exp. Metastasis 18, 111120.
  • Faulkner J. R., Herrmann J. E., Woo M. J., Tansey K. E., Doan N. B. and Sofroniew M. V. (2004) Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24, 21432155.
  • Ferrari C. C., Depino A. M., Prada F., Muraro N., Campbell S., Podhajcer O., Perry V. H., Anthony D. C. and Pitossi F. J. (2004) Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am. J. Pathol. 165, 18271837.
  • Ferrari C. C., Pott Godoy M. C., Tarelli R., Chertoff M., Depino A. M. and Pitossi F. J. (2006) Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra. Neurobiol. Dis. 24, 183193.
  • Gardner J. and Ghorpade A. (2003) Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J. Neurosci. Res. 74, 801806.
  • Gardner J., Borgmann K., Deshpande M. S., Dhar A., Wu L., Persidsky R. and Ghorpade A. (2006) Potential mechanisms for astrocyte-TIMP-1 downregulation in chronic inflammatory diseases. J. Neurosci. Res. 83, 12811292.
  • Gris P., Tighe A., Levin D., Sharma R. and Brown A. (2007) Transcriptional regulation of scar gene expression in primary astrocytes. Glia 55, 11451155.
  • Heales S. J., Lam A. A., Duncan A. J. and Land J. M. (2004) Neurodegeneration or neuroprotection: the pivotal role of astrocytes. Neurochem. Res. 29, 513519.
  • Herrmann J. E., Imura T. and Song B. et al. (2008) STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 28, 72317243.
  • Hornebeck W. (2003) Down-regulation of tissue inhibitor of matrix metalloprotease-1 (TIMP-1) in aged human skin contributes to matrix degradation and impaired cell growth and survival. Pathol. Biol. (Paris) 51, 569573.
  • Jaworski D. M. (2000) Differential regulation of tissue inhibitor of metalloproteinase mRNA expression in response to intracranial injury. Glia 30, 199208.
  • Jourquin J., Tremblay E. and Bernard A. et al. (2005) Tissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memory. Eur. J. Neurosci. 22, 25692578.
  • La Fleur M., Underwood J. L., Rappolee D. A. and Werb Z. (1996) Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J. Exp. Med. 184, 23112326.
  • Laird M. D., Vender J. R. and Dhandapani K. M. (2008) Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 16, 154164.
  • Lindl K. A., Marks D. R., Kolson D. L. and Jordan-Sciutto K. L. (2010) HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J. Neuroimmune Pharmacol. 5, 294309.
  • Liu J., Zhao M.-L., Brosnan C. F. and Lee S. C. (1996) Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1beta and IL-1 receptor antagonist. J. Immunol., 157, 35693576.
  • Lorenzl S., Albers D. S., Narr S., Chirichigno J. and Beal M. F. (2002) Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson’s disease. Exp. Neurol. 178, 1320.
  • Lorenzl S., Albers D. S., LeWitt P. A., Chirichigno J. W., Hilgenberg S. L., Cudkowicz M. E. and Beal M. F. (2003) Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. J. Neurol. Sci. 207, 7176.
  • Lorenzl S., Buerger K., Hampel H. and Beal M. F. (2008) Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia. Int. Psychogeriatr. 20, 6776.
  • Manthrope M., Fagnani R., Skaper S. D. and Varon S. (1986) An automated colorimetric microassay for neurotrophic factors. Dev. Brain Res. 25, 191198.
  • Menard C., Hein P. and Paquin A. et al. (2002) An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis. Neuron 36, 597610.
  • Nadeau S., Hein P., Fernandes K. J., Peterson A. C. and Miller F. D. (2005) A transcriptional role for C/EBP beta in the neuronal response to axonal injury. Mol. Cell. Neurosci. 29, 525535.
  • Oberheim N. A., Takano T. and Han X. et al. (2009) Uniquely hominid features of adult human astrocytes. J. Neurosci. 29, 32763287.
  • Ould-yahoui A., Tremblay E. and Sbai O. et al. (2009) A new role for TIMP-1 in modulating neurite outgrowth and morphology of cortical neurons. PLoS ONE 4, e8289.
  • Pagenstecher A., Stalder A. K., Kincaid C. L., Shapiro S. D. and Campbell I. L. (1998) Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am. J. Pathol. 152, 729741.
  • Panenka W., Jijon H., Herx L. M., Armstrong J. N., Feighan D., Wei T., Yong V. W., Ransohoff R. M. and MacVicar B. A. (2001) P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J. Neurosci. 21, 71357142.
  • Phillips B. W., Sharma R., Leco P. A. and Edwards D. R. (1999) A sequence-selective single-strand DNA-binding protein regulates basal transcription of the murine tissue inhibitor of metalloproteinases-1 (Timp-1) gene. J. Biol. Chem. 274, 2219722207.
  • Rivera S., Tremblay E., Timsit S., Canals O., Ben-Ari Y. and Khrestchatisky M. (1997) Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response. J. Neurosci. 17, 42234235.
  • Sandhir R. and Berman N. E. (2010) Age-dependent response of CCAAT/enhancer binding proteins following traumatic brain injury in mice. Neurochem. Int. 56, 188193.
  • Sears R. C. and Sealy L. (1994) Multiple forms of C/EBP beta bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat. Mol. Cell. Biol. 14, 48554871.
  • Sofroniew M. V. (2005) Reactive astrocytes in neural repair and protection. Neuroscientist 11, 400407.
  • Sofroniew M. V. and Vinters H. V. (2010) Astrocytes: biology and pathology. Acta Neuropathol. 119, 735.
  • Sterneck E. and Johnson P. F. (1998) CCAAT/enhancer binding protein beta is a neuronal transcriptional regulator activated by nerve growth factor receptor signaling. J. Neurochem. 70, 24242433.
  • Suryadevara R., Holter S., Borgmann K., Persidsky R., Labenz-Zink C., Persidsky Y., Gendelman H. E., Wu L. and Ghorpade A. (2003) Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia. Glia 44, 4756.
  • Yadav A. and Collman R. G. (2009) CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J. Neuroimmune Pharmacol. 4, 430447.
  • Yong V. W., Krekoski C. A., Forsyth P. A., Bell R. and Edwards D. R. (1998) Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21, 7580.
  • Yukawa K., Tanaka T., Tsuji S. and Akira S. (1998) Expressions of CCAAT/Enhancer-binding proteins beta and delta and their activities are intensified by cAMP signaling as well as Ca2+/calmodulin kinases activation in hippocampal neurons. J. Biol. Chem. 273, 3134531351.